×
Hero Background

Hypertension Drugs Companies

ID: MRFR/Pharma/1967-HCR
55 Pages
Rahul Gotadki
October 2025

Hypertension, or high blood pressure, is a common medical condition that often requires ongoing management with antihypertensive medications.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Middle-East and Africa Hypertension Drugs Market- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Hypertension Drugs Market

Middle-East and Africa Hypertension Drugs Key Companies

 

Latest Middle-East and Africa Hypertension Drugs Companies Update


Pfizer partners with local distributors in Egypt and Morocco: July 2023, Pfizer announced partnerships with local distributors in Egypt and Morocco to improve access to its portfolio of antihypertensive medications, including Accuretic (lisinopril/ hydrochlorothiazide) and Zestril (lisinopril).


Novartis launches Sandoz Generics hypertension portfolio in Nigeria: June 2023, Novartis launched its Sandoz Generics portfolio of hypertension medications in Nigeria, offering affordable options for patients with limited access to branded drugs.


Sanofi expands access to Entresto (sacubitril/valsartan) in South Africa: May 2023, Sanofi secured expanded access to Entresto, a first-line treatment for heart failure with preserved ejection fraction (HFpEF), in South Africa through private insurance coverage.


List of Middle-East and Africa Hypertension Drugs Key Companies in the Market



  • Abbott (US)

  • Johnson & Johnson Services Inc. (US)

  • Novartis (Switzerland)

  • GlaxoSmithKline plc.(UK)

  • AstraZeneca (UK)

  • Bayer AG (Germany)

  • Pfizer Inc.(US)

  • Merck & Co. Inc. (US)

  • Sanofi (France)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Gilead (US)